Metabolic Changes in Chronic HCV Patients Receiving DAAS - Trial NCT04211844
Access comprehensive clinical trial information for NCT04211844 through Pure Global AI's free database. This phase not specified trial is sponsored by Ain Shams University and is currently status unknown. The study focuses on Chronic Hepatitis C. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ain Shams University
Timeline & Enrollment
N/A
Oct 01, 2019
Apr 01, 2020
Primary Outcome
Change from baseline Total Lipid Profile within 6 months,Change from baseline Glycosylated Hemoglobin within 6 months,Change from baseline Fasting Blood Glucose within 6 months
Summary
Observational Study to check metabolic changes between two different hepatitis C antiviral
 medication groups. This study will evaluate the impact of different treatments on Serum lipid
 changes, fasting blood glucose and glycated hemoglobin . It will determine if changes are due
 to different Antiviral regimens or due to different Sustained virological response rates.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04211844
Non-Device Trial